Showing results (41-50 of 55) with videos related to
Sort By:
Pageof 6
Acta Neurologica Scandinavica|September 17, 2013
Natalizumab saturation: biomarker for individual treatment holiday after natalizumab withdrawal?P Wipfler, A Harrer, G Pilz, et al.Journal of Neurology|August 10, 2012
Circadian rhythmicity of inflammatory serum parameters: a neglected issue in the search of biomarkers in multiple sclerosisP Wipfler, A Heikkinen, A Harrer, et al.Shock (Augusta, Ga.)|April 1, 1994
Repeated administration of a F(ab')2 fragment of an anti-tumor necrosis factor alpha monoclonal antibody in patients with severe sepsis: effects on the cardiovascular system and cytokine levelsP Boekstegers, S Weidenhöfer, R Zell, et al.European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|March 29, 2000
Improved outcome of APACHE II score-defined escalating systemic inflammatory response syndrome in patients post cardiac surgery in 1996 compared to 1988-1990: the ESSICS-study pilot projectC Kuhn, U Müller-Werdan, D V Schmitt, et al.Epilepsy & Behavior : E&B|May 13, 2015
Perampanel in patients with refractory and super-refractory status epilepticus in a neurological intensive care unitA Rohracher, J Höfler, G Kalss, et al.Medizinische Klinik, Intensivmedizin Und Notfallmedizin|September 29, 2016
Serum IgG levels and mortality in patients with severe sepsis and septic shock : The SBITS dataS Dietz, C Lautenschläger, U Müller-Werdan, et al.Epilepsy & Behavior : E&B|June 15, 2015
Predicting outcome of status epilepticusM Leitinger, G Kalss, A Rohracher, et al.Clinical and Experimental Immunology|April 25, 2013
Glatiramer acetate attenuates the pro-migratory profile of adhesion molecules on various immune cell subsets in multiple sclerosisJ Sellner, W Koczi, A Harrer, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|October 13, 2010
Adhesion molecules are promising candidates to establish surrogate markers for natalizumab treatmentP Wipfler, K Oppermann, G Pilz, et al.Clinical and Experimental Immunology|January 22, 2015
High interindividual variability in the CD4/CD8 T cell ratio and natalizumab concentration levels in the cerebrospinal fluid of patients with multiple sclerosisA Harrer, G Pilz, P Wipfler, et al.Pageof 6